4PX6
SYK catalytic domain in complex with a potent pyridopyrimidinone inhibitor
Summary for 4PX6
Entry DOI | 10.2210/pdb4px6/pdb |
Descriptor | Tyrosine-protein kinase SYK, 7-{[(1R,2S)-2-aminocyclohexyl]amino}-5-(1H-indol-7-ylamino)pyrido[4,3-d]pyrimidin-4(3H)-one (3 entities in total) |
Functional Keywords | kinase domain, phosphotransferase, transferase-transferase inhibitor complex, transferase/transferase inhibitor |
Biological source | Homo sapiens (human) |
Cellular location | Cell membrane (Probable): P43405 |
Total number of polymer chains | 1 |
Total formula weight | 34245.38 |
Authors | Lee, C.C. (deposition date: 2014-03-21, release date: 2014-04-23, Last modification date: 2023-09-20) |
Primary citation | Thoma, G.,Blanz, J.,Buhlmayer, P.,Druckes, P.,Kittelmann, M.,Smith, A.B.,van Eis, M.,Vangrevelinghe, E.,Zerwes, H.G.,Che, J.J.,He, X.,Jin, Y.,Lee, C.C.,Michellys, P.Y.,Uno, T.,Liu, H. Syk inhibitors with high potency in presence of blood. Bioorg.Med.Chem.Lett., 24:2278-2282, 2014 Cited by PubMed Abstract: We describe two series of Syk inhibitors which potently abrogate Syk kinase function in enzymatic assays, cellular assays and in primary cells in the presence of blood. Introduction of a 7-aminoindole substituent led to derivatives with good kinase selectivity and little or no hERG channel inhibition (3b, 10c). PubMed: 24726806DOI: 10.1016/j.bmcl.2014.03.075 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.6 Å) |
Structure validation
Download full validation report